Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Socioeconomic Impact of Spasmodic Dysphonia Patients and the Role of Botulinum Toxin

NCT06561334 is registered in ClinicalTrials.gov with Manchester University NHS Foundation Trust as lead sponsor.

NCT NCT06561334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06561334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Socioeconomic Impact of Spasmodic Dysphonia Patients and the Role of Botulinum Toxin
Lead sponsor
Manchester University NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
August 20, 2024
Completion date
September 30, 2025
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

quality of life, spasmodic dysphonia